🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to devise a safe and effective method for tran...
Status
Completed
Location
UMDNJ Clinical Research Center
Start Date
2003-10
Trial ID
NCT00143806
Treatments Being Tested
Alefacept is a new anti-psoriatic drug within the group of the so-called bi...
Status
Completed
Location
Medical University of Graz
Start Date
2004-02
Trial ID
NCT00407342
Treatments Being Tested
This is a single-center, open-label, pilot study. A total of 18 subjects wi...
Status
Completed
Location
UCSF Psoriasis and Skin Treatment Center
Start Date
2007-09
Trial ID
NCT00678470
Treatments Being Tested
The purpose of this study is to assess Alefacept in combination with alemtu...
Status
Terminated
Location
Northwestern Memorial Hospital
Start Date
2010-07
Trial ID
NCT01163799
Treatments Being Tested
To determine the mechanism of action of alefacept in patients with psoriasi...
Status
Completed
Location
UMDNJ Clinical Research Center
Start Date
2003-09
Trial ID
NCT00150982
Treatments Being Tested
RATIONALE: Combinations of biological substances in alefacept may be able t...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2006-03
Trial ID
NCT00438802
Treatments Being Tested
Alefacept (AMEVIVE®) is an immunosuppressive dimeric fusion protein. It was...
Status
Terminated
Location
Department of Stem Cell Transplantation & Cancer Immunotherapy
Start Date
2006-06
Trial ID
NCT00361413
Treatments Being Tested
The purpose of this study is to determine whether alefacept is effective an...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00617604
Treatments Being Tested
Aplastic Anemia (AA) is an autoimmune hematologic stem cell disease mediate...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2011-05
Trial ID
NCT01267643
Treatments Being Tested
To assess the efficacy and safety of Alefacept compared to placebo for the ...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00673556